Literature DB >> 9855699

Carboxyflavins, novel inhibitors of Taq DNA polymerase.

Y Mizushina1, T Ueno, Y Goto, Y Isobe, M Sako, T Fujita, K Hirota, H Hayashi, K Sakaguchi.   

Abstract

Carboxyflavins were found to be potent selective inhibitors of Taq DNA polymerase in a polymerase chain reaction. The inhibitions were dose-dependent, and complete inhibitions were observed at the concentration of 3.0 microM. Carboxyflavins were much less, or not sensitive to the DNA polymerases tested such as calf thymus DNA polymerase alpha, rat DNA polymerase beta, human immunodeficiency virus type 1 reverse transcriptase, the Klenow Fragment of E. coli DNA polymerase I and T4 DNA polymerase. To our knowledge, there is no other report of an agent that selectively inhibits only a thermophilic polymerase. Interestingly, the carboxyflavins were able to prevent DNA synthesis in the murine lymphoid leukemia cell line L1210 in vitro; almost complete inhibitory levels were achieved in the range of less than 10 microM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855699     DOI: 10.3892/ijmm.2.3.283

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  2 in total

1.  Inhibitory action of emulsified sulfoquinovosyl acylglycerol on mammalian DNA polymerases.

Authors:  Yoshiyuki Mizushina; Naoki Maeda; Miho Kawasaki; Hideki Ichikawa; Chikako Murakami; Masaharu Takemura; Xianai Xu; Fumio Sugawara; Yoshinobu Fukumori; Hiromi Yoshida; Kengo Sakaguchi
Journal:  Lipids       Date:  2003-10       Impact factor: 1.880

2.  Structure-activity relationship of a novel group of mammalian DNA polymerase inhibitors, synthetic sulfoquinovosylacylglycerols.

Authors:  S Hanashima; Y Mizushina; K Ohta; T Yamazaki; F Sugawara; K Sakaguchi
Journal:  Jpn J Cancer Res       Date:  2000-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.